Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R6LF
|
|||
| Drug Name |
Citalopram derivative 1
|
|||
| Synonyms |
PMID29334795-Compound-59
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H21FN2O
|
|||
| Canonical SMILES |
CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
|
|||
| InChI |
1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
|
|||
| InChIKey |
WSEQXVZVJXJVFP-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 59729-33-8
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:77397
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017).Expert Opin Ther Pat. 2018 Mar;28(3):175-196. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.